Company Profile

Mereo BioPharma Group plc (NASDAQ: MREO)
5:00 PM UTC, 07/03/24
Last: $3.59 Change: +0.14 %Change: +4.06% Volume: 298,573
Detailed Quote
Open: $ 3.40   Volume: 298,573
High: $ 3.61   Yield(%) 0.00
Low: $ 3.37   P/E Ratio (ttm): n/a
Dividend ($): n/a   Market Cap ($): 483.93M
EPS ($) -0.06   Shares Out: 140.27M
M = Million B = Billion
Price Performance
% Price Change (last 4 weeks): 3.60
% Price Change (last 13 weeks): 2.07
% Price Change (last 26 weeks): 50.00
% Price Change (last 52 weeks): 167.44
% Price Change (year to date): 49.35
Management Effectiveness
Return on Equity (%): -47.34
Return on Assets (%): -34.31
Return on Invested Capital (%): -135.65
Profitability
Gross Profit Margin (%): 63.65
Net Profit Margin (%): -294.66
Operating Profit Margin (%): -284.16
Price & Volume
50-day Moving Average: $3.33
200-day Moving Average: $2.77
Avg. Daily Vol. (last 50 days): 1,144,898
Avg. Daily Vol. (last 200 days): 1,341,357
52-wk high: $4.50
52-wk low: $1.07
Bid: $3.45
Ask: $3.61
Company Information
Mereo BioPharma Group Plc is a biopharmaceutical company, which engages in the development and commercialization of therapeutics that aim to improve outcomes for oncology and rare diseases. Its portfolio include Etigilimab (MPH-313), Alvelestat (MPH-966), Setrusumab (BPS-804), Navicixizumab (OMP-305B83), Acumapimod (BCT-197), and Leflutrozole (BGS-649). The company was founded by Denise Vera Scots-Knight, Charles Edward Sermon, Alastair Graham MacKinnon, and John P. Richard in March 10, 2015 and is headquartered in London, the United Kingdom.
Mereo BioPharma Group plc
1 Cavendish Place 4th Floor
London GL W1G 0QF

Phone: 44.333.023.7300
Fax: n/a
http://www.mereobiopharma.com
Per Share Data
Earnings (1year) ($): -0.25
Annual Dividend ($): 0.00
Current P/E Ratio (ttm): n/a
Book Value ($): 0.36
Cash Flow ($): -0.20
Valuation Ratios
Price/Earnings (x): n/a
Price/Sales (x): 30.35
Price/Book (x): 6.40
Price/Cash Flow (x): n/a
Financial Strength
Quick Ratio (x): 6.72
Current Ratio (x): 6.72
LT Debt/Equity (x): 10.49
Total Debt/Equity (x): 11.78



Quotes displayed with 15 minutes delay. Market data provided by Factset. Powered and implemented by FactSet Digital Solutions. Legal Statement. News provided by MT Newswires, a Division of MidnightTrader, Inc. Events Data provided by Wall Street Horizon. ©2020 Wall Street Horizon, Inc.